Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Evolent Health (DE:9EH)
BERLIN:9EH
Evolent Health (9EH) Stock Price & Analysis
0 Followers
9EH Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€22.40 - €32.40
Previous Close€25.8
Volume0.00
Average Volume (3M)40.00
Market Cap
€2.94B
Enterprise Value€3.36B
Total Cash (Recent Filing)$192.82M
Total Debt (Recent Filing)$644.80M
Price to Earnings (P/E)N/A
Beta0.24
Next Earnings
May 09, 2024EPS Estimate
€0.2Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding115,430,107
10 Day Avg. Volume0
30 Day Avg. Volume40
Standard Deviation0.18
R-Squared0.09
Alpha0.03
Financial Highlights & Ratios
Price to Book (P/B)-3.93
Price to Sales (P/S)2.45
Price to Cash Flow (P/CF)8.80
P/FCF Ratio1.70
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.71
Enterprise Value/Gross Profit7.30
Enterprise Value/Ebitda-46.17
Forecast
1Y Price Target
€42.75Price Target Upside68.30% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering11
Evolent Health News
Bulls Say, Bears Say
Bulls Say
Financial GrowthForecasted revenue growth of 24.4% in 2024 is essentially all organic, showing strong underlying business performance.
Revenue GuidanceRevenue guidance for the upcoming year surpasses previous estimates.
Stock RecommendationAnalyst recommends BUY, with a price target adjusted to $44, reflecting confidence in the company's future performance.
Bears Say
Financial PerformanceInitial gross margins will be minimal for newly onboarded Performance Suite business, requiring time to ramp up and impact profitability.
Membership DeclineA projected decline in MDCD membership could reflect negatively on the company's performance in the healthcare sector.
Revenue ForecastThe forecast for added Specialty Tech and Services product lives in 2024 has been lowered, incorporating some conservatism for Medicaid redeterminations.
---
Options Prices
Currently, No data available
---
Ownership Overview
0.00% Insiders
0.00% Mutual Funds
1.21% Other Institutional Investors
98.79% Public Companies and
Individual Investors
9EH FAQ
What was Evolent Health’s price range in the past 12 months?
Evolent Health lowest stock price was €22.40 and its highest was €32.40 in the past 12 months.
What is Evolent Health’s market cap?
Currently, no data Available
When is Evolent Health’s upcoming earnings report date?
Evolent Health’s upcoming earnings report date is May 09, 2024 which is in 6 days.
How were Evolent Health’s earnings last quarter?
Evolent Health released its earnings results on Feb 22, 2024. The company reported €0.215 earnings per share for the quarter, beating the consensus estimate of €0.155 by €0.06.
Is Evolent Health overvalued?
According to Wall Street analysts Evolent Health’s price is currently Undervalued.
Does Evolent Health pay dividends?
Evolent Health does not currently pay dividends.
What is Evolent Health’s EPS estimate?
Evolent Health’s EPS estimate is €0.2.
How many shares outstanding does Evolent Health have?
Currently, no data Available
What happened to Evolent Health’s price movement after its last earnings report?
Evolent Health reported an EPS of €0.215 in its last earnings report, beating expectations of €0.155. Following the earnings report the stock price went up 10.87%.
Which hedge fund is a major shareholder of Evolent Health?
Among the largest hedge funds holding Evolent Health’s share is Engaged Capital LLC. It holds Evolent Health’s shares valued at 108M.
---
Evolent Health Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
€42.75 (68.30% Upside)
€42.75 (68.30% Upside)
Blogger Sentiment
Bullish
DE:9EH Sentiment 100%
Sector Average 70%
Sector Average 70%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-25.16%
12-Months-Change
Fundamentals
Return on Equity
-11.73%
Trailing 12-Months
Asset Growth
47.49%
Trailing 12-Months
Company Description
Evolent Health
Evolent Health, Inc. engages in the provision of health care delivery and payment services. Its solutions include population health management, health plan administration and third party administration, network performance management, risk adjustment, pharmacy benefit management, analytics and performance improvement, and technology and electronic medical record integration. The firm operates through Services segment and True Health segment. The Services segment includes three types of services designed to help partners manage patient health; value-based care services, specialty care management services and comprehensive health plan administration services. The True Health segment, which operates a health plan in New Mexico, and provides reinsurance to NMHC, takes on certain insurance and underwriting costs in pricing its premiums. The company was founded by Frank J. Williams, Seth B. Blackley, and Tom Peterson in August 2011 and is headquartered in Arlington, VA.
---
9EH Company Deck
---
9EH Earnings Call
Q4 2024
0:00 / 0:00
---
9EH Stock 12 Months Forecast
Average Price Target
€42.75
▲(68.30% Upside)
Technical Analysis
Best Analysts Covering 9EH
1 Year
1 Year Success Rate
25/47 ratings generated profit
1 Year Average Return
+22.85%
reiterated a buy rating last month
Copying Richard Close's trades and holding each position for 1 Year would result in 53.19% of your transactions generating a profit, with an average return of +22.85% per trade.
---